Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check7 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the record history, and the previous 'Revision: v3.6.4' entry was removed, representing an administrative update to the history log.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe history now includes a new entry for Revision: v3.6.4, and the previous Revision: v3.6.3 is removed from the list. This reflects an update to the version history rather than changes to the study content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous entry v3.6.0 was removed, indicating an update to the page's revision history.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history now shows recruitment has ended with 'No longer looking for participants', signalling cessation of enrollment. A new revision entry 'Revision: v3.6.0' was added, replacing the previous 'Revision: v3.5.5' in the version history.SummaryDifference0.4%

- Check71 days agoChange DetectedA new history revision (v3.5.5) has been added to the study record’s Version History, replacing the previous revision (v3.5.4).SummaryDifference0.1%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.